By GREGORY ZELLER // The National Institutes of Health is backing an early-stage Kings Park biotech’s quest for non-antibiotic-based COVID-19 treatments. CMTx Biotech has non-antimicrobials in its sights and a…
Tied with a bow: Welcome to Friday, dear readers, as we wrap up the last full workweek of the decade and unwrap a full slate of holiday celebrations. (With…
By GREGORY ZELLER // First, healthy teeth for dogs … then a cancer cure for the world? Financially and otherwise, Traverse Biosciences enjoyed a strong 2016 – but it may…